MetLife Investment Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $170K | Buy |
|
|||||
|
2025
Q1 | $83.8K | Hold |
|
|||||
|
2024
Q4 | $108K | Hold |
|
|||||
|
2024
Q3 | $143K | Hold |
|
|||||
|
2024
Q2 | $208K | Buy |
|
|||||
|
2024
Q1 | $173K | Hold |
|
|||||
|
2023
Q4 | $139K | Hold |
|
|||||
|
2023
Q3 | $139K | Hold |
|
|||||
|
2023
Q2 | $168K | Hold |
|
|||||
|
2023
Q1 | $173K | Hold |
|
|||||
|
2022
Q4 | $248K | Hold |
|
|||||
|
2022
Q3 | $242K | Hold |
|
|||||
|
2022
Q2 | $261K | Hold |
|
|||||
|
2022
Q1 | $408K | Buy |
|
|||||
|
2021
Q4 | $372K | Hold |
|
|||||
|
2021
Q3 | $216K | Hold |
|
|||||
|
2021
Q2 | $205K | Hold |
|
|||||
|
2021
Q1 | $273K | Buy |
|
|||||
|
2020
Q4 | $168K | Hold |
|
|||||
|
2020
Q3 | $122K | Buy |
|